{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-22-003369","form_type":"8-K","ticker":"ENTXW","cik":"0001638097","company_name":"Entera Bio Ltd.","filed_at":"2022-09-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.488721+00:00","generated_at":"2026-06-23T12:01:22.183023+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Entera Bio shareholders elect Yonatan Malca and approve all proposals at 2022 annual meeting","bullets":["Yonatan Malca elected to board for three-year term; 11,060,520 votes for, 47,457 against.","CEO Miranda Toledano's compensation ratified: 8,074,581 for, 2,959,002 against.","Amendment to 2018 equity plan increasing shares by 576,188 approved: 8,420,408 for.","Kesselman & Kesselman (PwC) ratified as auditor for FY2022 with 11,061,302 votes for."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-22-003369","json":"https://secwatch.observer/filing/0001178913-22-003369.json","markdown":"https://secwatch.observer/filing/0001178913-22-003369.md","text":"https://secwatch.observer/filing/0001178913-22-003369.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1638097/000117891322003369/0001178913-22-003369-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1638097/000117891322003369/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T12:01:22.183023+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}